In this single-centre study of 980 consecutive patients with AMI, increased values of copeptin (odds ratio: 4.14, P < 0.0005) measured between days 3 and 5 after AMI were associated with the primary end-point of death or heart failure at 60 days in multivariate analysis. The gene discussed is AVP; the disease is heart failure.